Private Equity Firm Healthcare

Eir Partners

Miami, Florida, United States

Eir Partners Capital, LP is a Miami-based private equity firm focused on healthcare technology and tech-enabled services. Founded in 2015, it partners with entrepreneurs and management teams to create scaled, strategically differentiated platforms across payer, provider, employer, and pharma technology sectors.

Focus Areas
Healthcare technology, Tech-enabled services, Health data & analytics
Website
eirpartners.com

Tracked deals

7

7 tracked deals across 2022-2026.

Recent pace

2

2 tracked deals announced in the last 12 months.

Deal mix

Recapitalization

3 recapitalization · 2 growth capital · 1 addon

Eir Partners Acquisition Volume by Year

Last 5 years

Acquisition volume by year Annual acquisition counts for the last 5 years for Eir Partners. 2 2022 1 2023 1 2024 1 2025 ~3 est. 2 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • Buyer
    ClaimsBridge, Eir Partners Capital
    Target
    DialysisPPO
    Location
    United States
    Type
    Addon

    ClaimsBridge announced a strategic investment from Eir Partners Capital to scale its end-to-end claim and network technology ecosystem for healthcare payers. In parallel, ClaimsBridge acquired DialysisPPO, which offers a patented ESRD and chronic dialysis cost containment program aimed at helping payers capture Medicare savings immediately.

  • Buyer
    Eir Partners
    Target
    QuartzBio

    Eir Partners acquired a controlling interest in QuartzBio, a life science technology company providing connected sample and biomarker intelligence for clinical-stage biopharma. The growth investment is intended to help QuartzBio expand its biomarker intelligence offerings and scale operations, while accelerating platform enhancements such as AI-driven automation, interoperability, and enterprise scalability.

  • Buyer
    Eir Partners
    Target
    Porter

    Eir Partners, a middle-market private equity firm focused on healthcare technology and tech-enabled services, has made a growth investment in Porter, a Baltimore-based care coordination and healthcare IT platform. The capital will support Porter’s technology and AI capabilities, expand its geographic footprint, and accelerate its care coordination programs focused on quality and risk adjustment across the U.S.

  • Buyer
    Eir Partners
    Target
    PharmaForceIQ
    Industry
    Cloud & SaaS
    Location
    Massachusetts and Florida, United States

    Eir Partners completed a majority recapitalization of PharmaForceIQ (PFIQ), an AI-driven omnichannel orchestration and measurement platform for pharmaceutical and life science companies. The investment will fund product development, key hires and continued accumulation of data assets to scale PFIQ's HCP and DTC omnichannel offerings.

  • Buyer
    New Mountain Capital, Eir Partners
    Target
    Apixio, ClaimLogiq
    Seller
    Centene Corporation
    Type
    Buyout

    Apixio and ClaimLogiq have completed a merger to form a combined, AI-driven healthcare data and analytics company branded as Apixio. The transaction is supported by New Mountain Capital (which acquired Apixio from Centene) with Eir Partners remaining a significant minority investor; the combined company will have more than 280 employees.

  • Buyer
    Eir Partners
    Target
    Helpware
    Industry
    IT Services

    Eir Partners, a Miami-based private equity firm, completed a majority recapitalization of Helpware, a Lexington, Kentucky-headquartered provider of digital customer experience, content control/verification and AI services. The recapitalization will support Helpware’s product investment and organic and inorganic growth as the company scales its global delivery model across fintech, e-commerce/retail, consumer services and healthcare verticals.

  • Buyer
    Eir Partners
    Target
    ClaimLogiq

    Eir Partners completed a growth recapitalization of ClaimLogiq, a Charleston-based healthcare SaaS platform that provides payment integrity and pre-payment solutions to health plans. Eir intends to use ClaimLogiq as a platform investment to accelerate product development, automation and synergistic acquisitions (including Medliminal and SyTrue) to broaden capabilities and drive savings for payer customers.

Related Acquisition Pages

Selling a company? Get in front of buyers like Eir Partners

Turn tracked acquisition activity into an outreach-ready buyer list.